Company: WELNF
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001104659-25-113213
Chunk: 47

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 47
---
the “Business Combination Meeting”).
If the shareholders of the Company approve the Business Combination at the Business Combination Meeting and the other conditions
to the Business Combination are then satisfied or will be satisfied or waived on or before the Termination Date, then the Company intends
to use its best efforts to complete the Business Combination on or before the Termination Date. The Company will cancel the Meeting and
will not implement the Extension if it is able to complete the Business Combination prior to the Meeting. The Company intends to hold
the Meeting to approve all above mentioned proposals, including the Extension Amendment Proposal, and file the proposed amendment to its
M&A only if it has determined that it will not be able to complete the Business Combination on or before the Termination Date. If
the Company does not implement the Extension, it will not redeem any public shares submitted for redemption solely in connection with
the Meeting (but will redeem all public shares submitted for redemption in connection with the Business Combination Meeting).

If the Extension is approved
and implemented, the Company intends to complete the Business Combination as soon as possible and in any event on or before the Extended
Date.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting of the Company shareholders and the solicitation of proxies from the Company shareholders in connection with such separate Business Combination Meeting, and the related right of the Company shareholders to redeem in connection with the Business Combination (which is a separate right to redeem in addition to the right to redeem in connection with the M&A Amendment Proposals), is the subject of a separate proxy statement/prospectus. If you want to ensure your Public Shares are redeemed in the event the M&A Amendments are approved at the Meeting, you should elect to “redeem” your Public Shares in connection with the Meeting.

<div align='center'>29

THE MEETING</div>

Date, Time and Place of the Meeting

The enclosed proxy is solicited
by the Board in connection with the extraordinary general meeting in lieu of an annual general meeting to be held on December 12,
2025 at 10:00 a.m. Eastern Time for the purposes set forth in the accompanying Notice of Meeting, at the offices of Ellenoff Grossman &
Schole LLP at 1345 Avenue of the Americas, 11 Floor, New York, New York 10105, or at such other time, on such other date
and at such other place to which the